19935800

Source:http://linkedlifedata.com/resource/pubmed/id/19935800

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0021756, umls-concept:C0031809, umls-concept:C0087111, umls-concept:C0205470, umls-concept:C0220901, umls-concept:C0812413
pubmed:issue	11
pubmed:dateCreated	2009-11-25
pubmed:abstractText	Administration of interleukin-2 (IL-2) has shown some effects on malignant pleural mesothelioma (MPM) tumour regression. The purpose of this study was to investigate the ability of IL-2 to modify immunological effector cells and angiogenesis in MPM patients and their prognostic value.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0370635
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/FOXP3 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Forkhead Transcription Factors, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2, http://linkedlifedata.com/resource/pubmed/chemical/Tryptases
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	1532-1827
pubmed:author	pubmed-author:BRUCC, pubmed-author:BoldriniLL, pubmed-author:CorsiVV, pubmed-author:Dell'OmodarmeMM, pubmed-author:FontaniniGG, pubmed-author:LucchiMM, pubmed-author:MussoGG, pubmed-author:PicchiAA, pubmed-author:PratiM CMC
pubmed:issnType	Electronic
pubmed:day	1
pubmed:volume	101
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1869-75
pubmed:dateRevised	2011-3-3
pubmed:meshHeading	pubmed-meshheading:19935800-Adult, pubmed-meshheading:19935800-Aged, pubmed-meshheading:19935800-Disease Progression, pubmed-meshheading:19935800-Female, pubmed-meshheading:19935800-Forkhead Transcription Factors, pubmed-meshheading:19935800-Humans, pubmed-meshheading:19935800-Immunohistochemistry, pubmed-meshheading:19935800-Interleukin-2, pubmed-meshheading:19935800-Lymphocytes, pubmed-meshheading:19935800-Lymphocytes, Tumor-Infiltrating, pubmed-meshheading:19935800-Male, pubmed-meshheading:19935800-Mast Cells, pubmed-meshheading:19935800-Mesothelioma, pubmed-meshheading:19935800-Middle Aged, pubmed-meshheading:19935800-Multivariate Analysis, pubmed-meshheading:19935800-Neovascularization, Pathologic, pubmed-meshheading:19935800-Pleural Neoplasms, pubmed-meshheading:19935800-Prognosis, pubmed-meshheading:19935800-Survival Rate, pubmed-meshheading:19935800-Treatment Outcome, pubmed-meshheading:19935800-Tryptases
pubmed:year	2009
pubmed:articleTitle	Treatment with interleukin-2 in malignant pleural mesothelioma: immunological and angiogenetic assessment and prognostic impact.
pubmed:affiliation	Division of Pathological Anatomy, Department of Surgery, University of Pisa, Via Roma 57, Pisa 56126, Italy.
pubmed:publicationType	Journal Article